期刊文献+

直肠癌中VEGF-D和uPA的表达与侵袭转移的关系 被引量:4

Expression of vascular endothelial growth factor D ( VEGF - D) and urokinase - type plasminogen activator in human rectal carcinoma and their relationship with tumor invasion and metastasis
原文传递
导出
摘要 目的 探讨血管内皮生长因子-D(VEGF-D)和尿激酶型纤维蛋白酶原激活剂(uPA)在直肠癌中的表达特点及临床意义。方法分别应用免疫组化SP法、Westernblot法检测30例直肠癌组织及相应正常组织的VEGF-D和uPA的表达特点,分析其与临床病理分期的关系。结果VEGF-D和uPA在肿瘤组织和正常组织中均有表达,主要表达于胞浆,胞核也有。在肿瘤组织中的表达明显高于正常组织(P〈0.01)。VEGF-D或uPA的表达活性在DukesC+D期明显高于A+B期(P〈0.01),在有淋巴结转移组和远处转移组的表达高于相应无转移组(P〈0.05、P〈0.01),随着肿瘤组织分化程度的增高活性依次降低(P〈0.05)。结论VEGF-D和uPA在肿瘤组织中的高表达可能在肿瘤的发生发展过程中扮演重要角色。 Objective To explore the expression of endothelial growth factor-D (VEGF -D) and uroki- nase-type plasminogen activator(uPA) in rectal carcinoma and to reveal their correlation to the tumor invasion and metastasis. Methods The expression of VEGF - D and uPA in 30 cases with rectal carcinoma and normal tissue was detected by immunohistochemistry and Western blot. Results The expression of VEGF - D and uPA was de- tected both in tumor tissue and normal tissue,but significantly higher in tumor tissue( P 〈 0. 01 ) , they expressed mostly in endoehylema. The expression of VEGF - D or uPA was significantly higher in Dukes' stage C + D than that in Dukes' stage A + B(P 〈0.01 ) , was also higher in tissues with lymph node metastasis or distant metasta- sis than those without metastasis(P 〈0.05,P 〈 0.01 ). They were found to be lower in cancer tissue along with the differentiation degree increase ( P 〈 0. 05 ) . Conclusions The overexpression of VEGF - D and uPA in rectal carcinoma may play an important part in the tumorigenesis and progression of rectal carcinoma.
出处 《中华内分泌外科杂志》 CAS 2009年第2期85-87,102,共4页 Chinese Journal of Endocrine Surgery
关键词 直肠癌 VEGF—D UPA Rectal Neoplasm or Carcinoma Vascular Endothelial Growth Factor D Urinary Plasminogen Activator
  • 相关文献

同被引文献38

  • 1鲁瑶,潘瑞芹,原田英也,上妻喜腾,高岛茂树,贾振庚.VEGF、MVD和CEA与大肠癌病理学特征及预后相关性的临床研究[J].中国实用外科杂志,2005,25(6):362-364. 被引量:12
  • 2冯刚,黄涛,卢宏达,费雁,冯觉平,孔庆志.莪术油注射液对小鼠移植性S180肉瘤血管形成的抑制作用[J].肿瘤研究与临床,2005,17(4):233-235. 被引量:33
  • 3吴胤瑛,李恩孝.VEGF在恶性肿瘤中的研究进展[J].现代肿瘤医学,2005,13(5). 被引量:56
  • 4Porter PL, Sage EH, Lane TF, et al. Distribution of SPARC innormal and neoplastic human tissue[J]. Histochem Cytochem,1995,43(8):791-800.
  • 5Alexandre C, Susan LC. Modulation of matrix remodeling bySPARC in neoplastic progression [ J]. Semin Cell Dev Biol,2010, 21 (1):55-65.
  • 6张雪梅,陈嘉薇,胡宏慧,等.乳腺浸润性导管癌中SPARC、KISS-1和KA11的表达和意义[D].上海:上海交通大学,2008.
  • 7Cheetham S,Tang MJ,Mesak F, et al. SPARC promoter hy-permethylation in colorectal cancers can be reversed by 5-Aza-2_deoxycytidine to increase SPARC expression and improve thera-py response[J]. Br J Cancer, 2008,98(11):1810-1819.
  • 8Barth PJ, Moll R,Ramaswamy A. Stromal remodeling andSPARC (secreted protein acid rich in cysteine) expression in in-vasive ductal carcinomas ofthe breast[JJ. Virchows Arch,2005,446(5):532-536.
  • 9Prada F,Benedetti LG, Bravo Al, et al. SPARC endogenouslevel, rather than fibroblast-produced SPARC or stroma reor-ganization induced by SPARC,is responsible for melanoma cell-growth[J]. Invest Dematol,2007,127(11) : 2618-2628.
  • 10Folkman J. Angiogenesis[ J]. Annu Rev Med, 2006,57 : 1-18.

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部